Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Jun-24 4:20 PM View:  | Arvinas, Inc. (ARVN) | 24-Jun-24 | Grant | 61,409 | -- | -- | 100% 0 to 61.41K | |
| 13-Nov-23 2:40 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 45,244 | $19.00 | $859,636.00 | (66%) 68.27K to 23.02K | |
| 13-Nov-23 2:40 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 23,021 | $19.00 | $437,399.00 | (100%) 23.02K to 0 | |
| 25-Sep-23 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 21-Sep-23 | Payment of Exercise | 908 | $10.80 | $9,806.40 | (1%) 69.17K to 68.27K | |
| 23-Jun-23 4:04 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 21-Jun-23 | Payment of Exercise | 908 | $11.74 | $10,659.90 | (1%) 70.08K to 69.17K | |
| 23-Mar-23 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 21-Mar-23 | Payment of Exercise | 909 | $14.19 | $12,898.70 | (1%) 70.99K to 70.08K | (6%) |
| 31-Jan-23 4:05 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Jan-23 | Grant | 14,700 | -- | -- | 26% 56.29K to 70.99K | |
| 03-Jan-23 4:04 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-22 | Payment of Exercise | 718 | $12.37 | $8,881.66 | (1%) 57.01K to 56.29K | |
| 23-Dec-22 4:03 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 21-Dec-22 | Payment of Exercise | 908 | $13.43 | $12,194.40 | (2%) 57.92K to 57.01K | (12%) |
| 23-Sep-22 4:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 21-Sep-22 | Payment of Exercise | 908 | $14.85 | $13,483.80 | (2%) 58.82K to 57.92K | (1%) |
| 23-Jun-22 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 21-Jun-22 | Payment of Exercise | 3,632 | $12.48 | $45,327.40 | (6%) 62.46K to 58.82K | |
| 31-Jan-22 4:16 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Jan-22 | Grant | 10,300 | -- | -- | 20% 52.16K to 62.46K | |
| 22-Jun-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 21-Jun-21 | Grant | 52,156 | -- | -- | 100% 0 to 52.16K | |
| 02-Jun-21 4:31 PM View: | Vyne Therapeutics Inc. (VYNE) | 28-May-21 | Grant | 3,017 | $3.36 | $10,129.60 | 3% 113.45K to 116.47K | |
| 02-Apr-21 12:14 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-21 | Payment of Exercise | 762 | $6.84 | $5,212.08 | (< 1%) 114.21K to 113.45K | (1%) |
| 24-Feb-21 4:39 PM View: | Vyne Therapeutics Inc. (VYNE) | 22-Feb-21 | Grant | 29,213 | -- | -- | 34% 85.0K to 114.21K | |
| 08-Sep-20 8:01 PM View: | Vyne Therapeutics Inc. (VYNE) | 08-Sep-20 | Market Purchase | 40,000 | $1.46 | $58,480.00 | 13% 300.0K to 340.0K | 21% |
| 08-May-20 5:54 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-May-20 | Grant | 250,000 | -- | -- | 500% 50.0K to 300.0K | |
| 24-Mar-20 4:31 PM View: | Vyne Therapeutics Inc. (VYNE) | 23-Mar-20 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 19-Feb-20 4:30 PM View: | Pds Biotechnology Corp (PDSB) | 14-Feb-20 | Grant | 38,400 | $1.30 | $49,920.00 | 926% 4.15K to 42.55K | 79% |
| 18-Mar-19 5:55 PM View: | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 82,999 | -- | -- | 100% 0 to 83.0K | |
| 30-Jan-15 9:38 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jan-15 | Disposition (other) | 10,000 | $36.53 | $365,300.00 | (100%) 10.0K to 0 | (2%) |
| 20-Aug-14 4:33 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Aug-14 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K |